Free Trial

Context Therapeutics (CNTX) Insider Trading & Ownership

Context Therapeutics logo
$0.66 -0.01 (-0.76%)
As of 04:00 PM Eastern

Context Therapeutics (NASDAQ:CNTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.04%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$107.21K
Number Of
Insiders Selling
(Last 12 Months)
0
Get CNTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Context Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CNTX Insider Buying and Selling by Quarter

Context Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/9/2025Martin A LehrCEOBuy100,000$0.70$70,000.00  
6/6/2025Alex C LevitInsiderBuy20,000$0.58$11,600.00  
6/6/2025Jennifer Lynn Minai-AzaryCFOBuy40,010$0.64$25,606.40  
(Data available from 1/1/2013 forward)

CNTX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Context Therapeutics includes Alex C Levit, Jennifer Lynn Minai-Azary, and Martin A Lehr. Learn more on insiders at CNTX.

3.04% of Context Therapeutics stock is owned by insiders. Learn more on CNTX's insider holdings.

The following insiders have purchased CNTX shares in the last 24 months: Alex C Levit ($11,600.00), Jennifer Lynn Minai-Azary ($25,606.40), and Martin A Lehr ($70,000.00).

Insiders have purchased a total of 160,010 CNTX shares in the last 24 months for a total of $107,206.40 bought.



This page (NASDAQ:CNTX) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners